Filing Details
- Accession Number:
- 0000899243-22-001169
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-06 16:06:27
- Reporting Period:
- 2022-01-04
- Accepted Time:
- 2022-01-06 16:06:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1743881 | Bridgebio Pharma Inc. | BBIO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1652908 | A. Douglas Dachille | C/O Bridgebio Pharma, Inc. 421 Kipling Street Palo Alto CA 94301 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-01-04 | 5,000 | $16.82 | 5,000 | No | 4 | P | Indirect | By The Dachille 2012-1 Family Trust |
| Common Stock | Acquisiton | 2022-01-05 | 5,000 | $15.91 | 10,000 | No | 4 | P | Indirect | By The Dachille 2012-1 Family Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By The Dachille 2012-1 Family Trust |
| No | 4 | P | Indirect | By The Dachille 2012-1 Family Trust |
Footnotes
- These shares are owned directly by The Dachille 2012-1 Family Trust for the benefit of the reporting person's children, for which the reporting person's spouse is the trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
Billionaire Hedge Funds
